- Home
- LYEL vs OLP Comparison
LYEL vs OLP Comparison
Compare LYEL & OLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LYEL | OLP |
|---|---|---|
| Founded | 2018 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 490.1M | 508.4M |
| IPO Year | 2021 | 1995 |
Fundamental Metrics
Financial Performance| Metric | LYEL | OLP |
|---|---|---|
| Price | $23.20 | $22.82 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 2 |
| Target Price | ★ $30.60 | $26.75 |
| AVG Volume (30 Days) | ★ 79.7K | 73.3K |
| Earning Date | 05-12-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 7.93% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 1.15 |
| Revenue | $36,000.00 | ★ $82,740,000.00 |
| Revenue This Year | N/A | $11.98 |
| Revenue Next Year | $16,285.34 | $3.71 |
| P/E Ratio | ★ N/A | $19.74 |
| Revenue Growth | N/A | ★ 1.02 |
| 52 Week Low | $0.39 | $19.62 |
| 52 Week High | $45.00 | $25.90 |
Technical Indicators
Market Signals| Indicator | LYEL | OLP |
|---|---|---|
| Relative Strength Index (RSI) | 55.91 | 57.52 |
| Support Level | $21.27 | $21.61 |
| Resistance Level | $27.30 | $23.38 |
| Average True Range (ATR) | 1.70 | 0.47 |
| MACD | 0.53 | 0.11 |
| Stochastic Oscillator | 75.83 | 91.82 |
Price Performance
Historical ComparisonAbout LYEL Lyell Immunopharma Inc.
Lyell Immunopharma Inc is a clinical-stage cell therapy company. It has a pipeline of product candidates for patients with solid tumors utilizing ex vivo genetic and epigenetic T-cell reprogramming technologies. The company's product pipeline includes, LYL797, LYL119, LYL845 among others.
About OLP One Liberty Properties Inc.
One Liberty Properties Inc is a self-administered and self-managed real estate investment trust. It acquires, owns, and manages a geographically diversified portfolio consisting mainly of industrial and, to a lesser extent, retail properties, many of which are subject to long-term net leases. The trust has approximately one hundred two properties located across several states in the United States of America. A majority of its revenue is generated in the form of rental income.